Christopher Ianelli's most recent trade in iSpecimen Inc was a trade of 10,000 Option done . Disclosure was reported to the exchange on Jan. 3, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
iSpecimen Inc | Christopher Ianelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,845 | - | - | Option | |
iSpecimen Inc | Christopher Ianelli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 845 | 10,000 | - | - | Option | |
iSpecimen Inc | Christopher Ianelli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 03 Jan 2023 | 845 | 425,359 | - | 1 | 845 | Common Stock |
iSpecimen Inc | Christopher Ianelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 92 | 425,451 | - | - | Common Stock | |
iSpecimen Inc | Christopher Ianelli | Director | Other type of transaction at price $ 0.00 per share. | 24 Oct 2022 | 18,229 | 424,514 | - | - | Common Stock | |
iSpecimen Inc | Christopher Ianelli | Director | Other type of transaction at price $ 0.00 per share. | 24 Oct 2022 | 564 | 845 | - | - | Option | |
iSpecimen Inc | Christopher Ianelli | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.36 per share. | 22 Jun 2022 | 3,903 | 442,743 | - | 2.4 | 9,211 | Common Stock |
iSpecimen Inc | Christopher Ianelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 48,106 | 1,409 | - | - | Option | |
iSpecimen Inc | Christopher Ianelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 22 Feb 2022 | 48,106 | 446,646 | - | 1 | 48,106 | Common Stock |
iSpecimen Inc | Christopher Ianelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 3,099 | 49,515 | - | - | Option | |
iSpecimen Inc | Christopher Ianelli | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 22 Feb 2022 | 3,099 | 398,540 | - | 1 | 3,099 | Common Stock |
iSpecimen Inc | Christopher Ianelli | Director, President & CEO | 31 Dec 2021 | 52,084 | 395,441 | - | - | Common Stock | ||
iSpecimen Inc | Christopher Ianelli | Director, CEO, President | 21 Jun 2021 | 2,663 | 0 | - | - | Series A Preferred Stock | ||
iSpecimen Inc | Christopher Ianelli | Director, CEO, President | 21 Jun 2021 | 2,663 | 343,357 | - | - | Common Stock |